Integrating genomics into biobehavioral research: A transplantation exemplar

Biological Research for Nursing

Volumn 13, Issue 4, 2011, Pages 340-345

  Driscoll, Carolyn J ^a   Lyon, Debra ^a   McCain, Nancy L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

biobehavioral research; biobehavioral transplantation model; liver transplantation; transplantation genetics genomics

Indexed keywords

ARTICLE; DIABETES MELLITUS; GENOMICS; GRAFT REJECTION; HEALTH BEHAVIOR; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVER TUMOR; NURSING RESEARCH; PHARMACOGENETICS; THEORETICAL MODEL;

CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; GENOMICS; GRAFT REJECTION; HEALTH BEHAVIOR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MODELS, THEORETICAL; NURSING RESEARCH; PHARMACOGENETICS;

EID: 80455164807     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800410389603     Document Type: Article

References (29)

1. Ader R. (2007). Psychoneuroimmunology. 4th ed.Amsterdam, Netherlands: Elsevier/Academic Press.Amsterdam, Netherlands: Elsevier/Academic Press; 2007:.
2. Barginear M. F.,Bradley T.,Shapira I.,Budman D. R.Implications of applied research for prognosis and therapy of breast cancer.Critical Reviews in Oncology and Hematology. 2008;65:223-234.
3. Bathgate A. J.,Pravica V.,Perrey C.,Therapondos G.,Plevris J. N.,Hayes P. C.,Hutchinson I. V.The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection.Transplantation. 2000;69:1514-1517.
4. Brouard S.,Ashton-Chess J.,Soulillou J. P.Surrogate markers for the prediction of long-term outcome in transplantation: Nantes Actualite Transplantation (NAT) 2007 meeting report.Human Immunology. 2008;69:2-8.
5. Charlton M.Obesity, hyperlipidemia, and metabolic syndrome.Liver Transplantation. 2009;15:S83-S89.
6. Chu Q. D.,Holm N.,Byrnes K.,Li B. D.Translational research in breast cancer.Surgical Oncology Clinics of North America. 2008;17:421 x-438.
7. Conley Y. P.,Tinkle M. B.The future of genomic nursing research.Journal of Nursing Scholarship. 2007;39:17-24.
8. Dick A. A.,Spitzer A. L.,Seifert C. F.,Deckert A.,Carithers R. L.,Reyes J. D.,Perkins J. D.Liver transplantation at the extremes of the body mass index.Liver Transplantation. 2009;15:968-977.
9. Drent G.,Moons P.,De Geest S.,Kleibeuker J. H.,Haagsma E. B.Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: Possible relationship with medication non-compliance?.Clinical Transplantation. 2008;22:700-709.
10. Driscoll C.Risk factors for posttransplant diabetes mellitus: A review of the literature.Progress in Transplantation. 2007;17:295-301.
11. Driscoll C. J.,Cashion A. K.,Hathaway D. K.,Thompson C.,Conley Y.,Riely C.,Homayouni R.Blood gene expression profiling in liver transplant recipients with hepatitis C and post transplant diabetes mellitus.Transplantation Proceedings. 2006;38:3646-3648.
12. Fernandes H.,Koneru B.,Fernandes N.,Hameed M.,Cohen M. C.,Raveche E.,Cohen S.Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients.Transplantation. 2002;73:1886-1891.
13. Fukudo M.,Yano I.,Yoshimura A.,Masuda S.,Uesugi M.,Hosohata K.,Inui K.Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.Pharmacogenetics and Genomics. 2008;18:413-423.
14. Goddard S.,Williams A.,Morland C.,Qin S.,Gladue R.,Hubscher S. G.,Adams D. H.Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants.Transplantation. 2001;72:1957-1967.
15. Guckelberger O.Long-term medical comorbidities and their management: Hypertension/cardiovascular disease.Liver Transplantation. 2009;15:S75-S78.
16. Ioannou G. N.,Perkins J. D.,Carithers R. L.Liver transplantation for hepatocellular carcinoma: Impact of the MELD allocation system and predictors of survival.Gastroenterology. 2008;134:1342-1351.
17. Kraemer H. C.,Stice E.,Kazdin A.,Offord D.,Kupfer D.How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors.American Journal of Psychiatry. 2001;158:848-856.
18. Krasnoff J. B.,Vintro A. Q.,Ascher N. L.,Bass N. M.,Paul S. M.,Dodd M. J.,Painter P. L.A randomized trial of exercise and dietary counseling after liver transplantation.American Journal of Transplantation. 2006;6:1896-1905.
19. Marder B. A.,Schroppel B.,Lin M.,Schiano T.,Parekh R.,Tomer Y.,Murphy B.The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation.American Journal of Transplantation. 2003;3:424-431.
20. Mas V. R.,Maluf D. G.,Archer K. J.,Yanek K.,Bornstein K.,Fisher R. A.Proteomic analysis of HCV cirrhosis and HCV-induced HCC: Identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.Transplantation. 2009;87:143-152.
21. McCain N. L.,Gray D. P.,Walter J. M.,Robins J.Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm.ANS. Advances in Nursing Science. 2005;28:320-332.
22. Mells G.,Neuberger J.Long-term care of the liver allograft recipient.Seminars in Liver Disease. 2009;29:102-120.
23. O'Carroll R. E.,McGregor L. M.,Swanson V.,Masterton G.,Hayes P. C.Adherence to medication after liver transplantation in Scotland: A pilot study.Liver Transplantation. 2006;12:1862-1868.
24. Pinsky B. W.,Takemoto S. K.,Lentine K. L.,Burroughs T. E.,Schnitzler M. A.,Salvalaggio P. R.Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression.American Journal of Transplantation. 2009;9:2597-2606.
25. Scherer M. N.,Banas B.,Mantouvalou K.,Schnitzbauer A.,Obed A.,Kramer B. K.,Schlitt H. J.Current concepts and perspectives of immunosuppression in organ transplantation.Langenbecks Archives of Surgery. 2007;392:511-523.
26. Schröppel B.,Fischereder M.,Ashkar R.,Lin M.,Krämer B. K.,Mardera B.,Murphy B.The impact of polymorphisms in chemokine and chemokine receptors on outcomes in liver transplantation.American Journal of Transplantation. 2002;2:640-645.
27. Sethi A.,Stravitz R. T.Review article: Medical management of the liver transplant recipient-A primer for non-transplant doctors.Alimentary Pharmacology and Therapeutics. 2007;25:229-245.
28. Smith H. E.,Jones J. P.,Kalhorn T. F.,Farin F. M.,Stapleton P. L.,Davis C. L.,Totah R. A.Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.Pharmacogenetics and Genomics. 2008;18:943-953.
29. van der Heide F.,Dijkstra G.,Porte R. J.,Kleibeuker J. H.,Haagsma E. B.Smoking behavior in liver transplant recipients.Liver Transplantation. 2009;15:648-655.